BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18986640)

  • 1. Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort.
    Mandelbrot L; Jasseron C; Ekoukou D; Batallan A; Bongain A; Pannier E; Blanche S; Tubiana R; Rouzioux C; Warszawski J;
    Am J Obstet Gynecol; 2009 Feb; 200(2):160.e1-9. PubMed ID: 18986640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
    Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F;
    Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
    Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
    AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No relation between in-utero exposure to HAART and intrauterine growth retardation.
    Briand N; Mandelbrot L; Le Chenadec J; Tubiana R; Teglas JP; Faye A; Dollfus C; Rouzioux C; Blanche S; Warszawski J;
    AIDS; 2009 Jun; 23(10):1235-43. PubMed ID: 19424054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire.
    Chaix ML; Ekouevi DK; Rouet F; Tonwe-Gold B; Viho I; Bequet L; Peytavin G; Toure H; Menan H; Leroy V; Dabis F; Rouzioux C;
    J Infect Dis; 2006 Feb; 193(4):482-7. PubMed ID: 16425126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
    Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
    Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twin pregnancy as a risk factor for mother-to-child transmission of HIV-1: trends over 20 years.
    Scavalli CP; Mandelbrot L; Berrebi A; Batallan A; Cravello L; Pannier E; Hamrene K; Ciraru-Vigneron N; Faye A; Warszawski J;
    AIDS; 2007 May; 21(8):993-1002. PubMed ID: 17457093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
    Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
    Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniocentesis in pregnant HIV-infected patients. Absence of mother-to-child viral transmission in a series of selected patients.
    Ekoukou D; Khuong-Josses MA; Ghibaudo N; Mechali D; Rotten D
    Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):212-7. PubMed ID: 18584937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission.
    Drake AL; John-Stewart GC; Wald A; Mbori-Ngacha DA; Bosire R; Wamalwa DC; Lohman-Payne BL; Ashley-Morrow R; Corey L; Farquhar C
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):403-9. PubMed ID: 17267842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001.
    Harris NS; Fowler MG; Sansom SL; Ruffo N; Lampe MA
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S33-41. PubMed ID: 17825649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
    Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
    Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series.
    Somigliana E; Bucceri AM; Tibaldi C; Alberico S; Ravizza M; Savasi V; Marini S; Matrone R; Pardi G;
    Am J Obstet Gynecol; 2005 Aug; 193(2):437-42. PubMed ID: 16098867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1.
    Burgard M; Jasseron C; Matheron S; Damond F; Hamrene K; Blanche S; Faye A; Rouzioux C; Warszawski J; Mandelbro L;
    Clin Infect Dis; 2010 Oct; 51(7):833-43. PubMed ID: 20804413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
    Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine cuts mother-infant infections.
    Lange J
    Glob AIDSnews; 1994; (1):10-1. PubMed ID: 12318811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
    Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
    HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial pattern of HIV-1 mother-to-child-transmission in Madrid (Spain) from 1980 till now: demographic and socioeconomic factors.
    Palladino C; Bellón JM; Perez-Hoyos S; Resino R; Guillén S; Garcia D; Gurbindo MD; Ramos JT; de José MI; Mellado MJ; Muñoz-Fernández MA
    AIDS; 2008 Oct; 22(16):2199-205. PubMed ID: 18832883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.